Blackrock CapEx decreased by 18.5% to $106.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.9%, from $78.00M to $106.00M. Over 2 years (FY 2022 to FY 2025), CapEx shows a downward trend with a -16.1% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $133.25M | $133.25M | $133.25M | $133.25M | $124.00M | $64.00M | $7.00M | $94.00M | $90.00M | $78.00M | $89.00M | $78.00M | $130.00M | $106.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -6.9% | -48.4% | -89.1% | >999% | -4.3% | -13.3% | +14.1% | -12.4% | +66.7% | -18.5% |
| YoY Change | — | — | — | — | -6.9% | — | — | — | -27.4% | +21.9% | >999% | -17.0% | +44.4% | +35.9% |